Royal Bank of Canada’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-94,260
| Closed | -$2.23M | – | 7158 |
|
2023
Q4 | $2.23M | Buy |
94,260
+22,811
| +32% | +$539K | ﹤0.01% | 2557 |
|
2023
Q3 | $1.07M | Buy |
71,449
+65,361
| +1,074% | +$974K | ﹤0.01% | 2951 |
|
2023
Q2 | $67K | Buy |
6,088
+6,062
| +23,315% | +$66.7K | ﹤0.01% | 5178 |
|
2023
Q1 | $0 | Sell |
26
-10,553
| -100% | – | ﹤0.01% | 7065 |
|
2022
Q4 | $66K | Buy |
10,579
+2,998
| +40% | +$18.7K | ﹤0.01% | 5269 |
|
2022
Q3 | $27K | Buy |
7,581
+6,331
| +506% | +$22.5K | ﹤0.01% | 5542 |
|
2022
Q2 | $4K | Sell |
1,250
-3,979
| -76% | -$12.7K | ﹤0.01% | 6309 |
|
2022
Q1 | $16K | Sell |
5,229
-8,482
| -62% | -$26K | ﹤0.01% | 6249 |
|
2021
Q4 | $46K | Buy |
13,711
+5,105
| +59% | +$17.1K | ﹤0.01% | 5888 |
|
2021
Q3 | $31K | Buy |
8,606
+2,456
| +40% | +$8.85K | ﹤0.01% | 5931 |
|
2021
Q2 | $27K | Sell |
6,150
-1,128
| -15% | -$4.95K | ﹤0.01% | 5904 |
|
2021
Q1 | $33K | Buy |
7,278
+5,698
| +361% | +$25.8K | ﹤0.01% | 5645 |
|
2020
Q4 | $9K | Buy |
1,580
+309
| +24% | +$1.76K | ﹤0.01% | 5895 |
|
2020
Q3 | $9K | Sell |
1,271
-1,042
| -45% | -$7.38K | ﹤0.01% | 5480 |
|
2020
Q2 | $8K | Sell |
2,313
-11,659
| -83% | -$40.3K | ﹤0.01% | 5446 |
|
2020
Q1 | $20K | Buy |
+13,972
| New | +$20K | ﹤0.01% | 5061 |
|
2019
Q4 | – | Sell |
-131
| Closed | -$1K | – | 6409 |
|
2019
Q3 | $1K | Sell |
131
-21
| -14% | -$160 | ﹤0.01% | 5862 |
|
2019
Q2 | $1K | Sell |
152
-50
| -25% | -$329 | ﹤0.01% | 5780 |
|
2019
Q1 | $2K | Buy |
202
+108
| +115% | +$1.07K | ﹤0.01% | 5542 |
|
2018
Q4 | $1K | Sell |
94
-1,013
| -92% | -$10.8K | ﹤0.01% | 5707 |
|
2018
Q3 | $12K | Buy |
+1,107
| New | +$12K | ﹤0.01% | 5306 |
|
2018
Q2 | – | Sell |
-1,200
| Closed | -$16K | – | 6128 |
|
2018
Q1 | $16K | Buy |
+1,200
| New | +$16K | ﹤0.01% | 4936 |
|
2017
Q4 | – | Sell |
-5
| Closed | – | – | 6114 |
|
2017
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 6179 |
|